Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
BIVM Biologics Sequence Review Report 2026: Basic immunoglobulin-like variable motif-containing protein Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BIVM protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BDKRB2 Biologics Sequence Review Report 2026: B2 bradykinin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BDKRB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BDKRB1 Biologics Sequence Review Report 2026: B1 bradykinin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BDKRB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
AVPR2 Biologics Sequence Review Report 2026: Vasopressin V2 receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of AVPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BAGE2 Biologics Sequence Review Report 2026: B melanoma antigen 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BAGE2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BAGE3 Biologics Sequence Review Report 2026: B melanoma antigen 3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BAGE3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BCAP29 Biologics Sequence Review Report 2026: B-cell receptor-associated protein 29 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BCAP29 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
AVPR1B Biologics Sequence Review Report 2026: Vasopressin V1b receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of AVPR1B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ATP6AP2 Biologics Sequence Review Report 2026: Renin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ATP6AP2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
AVPR1A Biologics Sequence Review Report 2026: Vasopressin V1a receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of AVPR1A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ASGR2 Biologics Sequence Review Report 2026: Asialoglycoprotein receptor 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ASGR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ANTXR2 Biologics Sequence Review Report 2026: Anthrax toxin receptor 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ANTXR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
53
54
55
56
57
>>
1620
>